T cell clones (TCC) were raised from the peripheral blood of patients suffering from tree pollen allergy. All TCC were restricted by HLA-DR molecules. In order to investigate possible intervention targets in Type 1 allergic diseases, we have examined T cell receptor (TCR) α and β-chain nucleotide sequences of several allergen-reactive human CD4+ TCC specific for four frequently found epitopes of Bet v 1, the major birch pollen allergen. In general, TCC specific for the 4 epitopes investigated, used diverse TCRAV and TCRBV gene segments. Moreover, the junctional regions encoding the third complementarity determining regions (CDR3) of the TCR showed striking heterogeneities in length and amino acid composition. A more restricted use of two J gene segments (TCRBJ1S4 and 2S7) was only observed in the β-chain of TCR used by TCC specific fur epitope 1. In addition, all TCC specific for epitope 4 showed an arginine residue in the N-terminal region of their TCRBV CDR3 loops despite their sequence diversities. In view of the striking heterogeneities found, therapeutical strategies aimed at the clonal deletion of allergen-specific T cell clones, providing help for IgE synthesis, may not be feasible. Moreover, our results cast a doubt on the theory, that the CDR3 exclusively provides the primary contact with the peptide bound in the major histocompatibility (MHC) groove, and suggest additional interaction with MHC class II.
CITATION STYLE
Breiteneder, H., Hajek, R., Hüttinger, R., Ebner, C., Schenk, S., Kraft, D., & Scheiner, O. (1996). Diversity of human T cell receptor sequences of T cell clones with specificity for Bet v 1 peptide/MHC II complexes. In Advances in Experimental Medicine and Biology (Vol. 409, pp. 365–374). Springer New York LLC. https://doi.org/10.1007/978-1-4615-5855-2_52
Mendeley helps you to discover research relevant for your work.